Literature DB >> 16534222

Atherosclerosis and vascular calcification in chronic renal failure.

V Campean1, D Neureiter, I Varga, F Runk, A Reiman, C Garlichs, S Achenbach, B Nonnast-Daniel, K Amann.   

Abstract

Cardiovascular complications are a major clinical problem in patients with chronic kidney disease and end-stage renal failure; cardiac death accounts for approximately 40-50% of all deaths in these patients. Death from cardiovascular causes is up to 20 times more common in uremic patients than in the general population with the risk being even higher than in patients with diabetes mellitus. A high rate of myocardial infarction and excessive cardiac mortality have repeatedly been documented in patients with kidney disease and renal failure. Not only is the prevalence of myocardial infarction high, but also the case fatality rate is significantly higher in uremic patients with and without diabetes, respectively, compared to nonuremic patients. This is of particular interest since the prevalence of coronary atheroma in uremic patients was shown to be approximately 30% by autopsy and coronary angiography studies. Thus, coronary factors, i.e. atherosclerosis, and non-coronary factors may play an important role in the genesis of cardiac complications in the renal patient. In addition, renal failure recently has also be identified as a predictor of mortality in different stages of peripheral vascular disease. In particular, marked differences in the pathogenesis, morphology and course of atherosclerosis and arteriosclerosis under the conditions of renal failure have been documented. Among others increased plaque formation and particularly higher proportion and intensity of vascular calcification have been found in clinical and autopsy studies. In addition to the so-called classical or traditional risk factors, an important role for nonclassical risk factors such as microinflammation, hyperphosphatemia and oxidative stress has been documented in patients with renal failure and is discussed in detail. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534222     DOI: 10.1159/000090182

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  21 in total

1.  Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Authors:  Yuji Kuge; Nozomi Takai; Yuki Ogawa; Takashi Temma; Yan Zhao; Kantaro Nishigori; Seigo Ishino; Junko Kamihashi; Yasushi Kiyono; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

2.  Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease.

Authors:  Jose-Luiz Figueiredo; Masanori Aikawa; Chunyu Zheng; Jacob Aaron; Lilian Lax; Peter Libby; Jose Luiz de Lima Filho; Sabine Gruener; Jürgen Fingerle; Wolfgang Haap; Guido Hartmann; Elena Aikawa
Journal:  Am J Pathol       Date:  2015-02-10       Impact factor: 4.307

Review 3.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

4.  Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation.

Authors:  Yang Zhao; Ming-Ming Zhao; Yan Cai; Ming-Fei Zheng; Wei-Liang Sun; Song-Yang Zhang; Wei Kong; Jun Gu; Xian Wang; Ming-Jiang Xu
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

5.  Activation of platelets upon contact with a vitamin E-coated/non-coated surface.

Authors:  Hiroshi Tsukao; Kenichi Kokubo; Haruko Takahashi; Mina Nagasato; Takanori Endo; Naoto Iizuka; Toshihiro Shinbo; Minoru Hirose; Hirosuke Kobayashi
Journal:  J Artif Organs       Date:  2013-02-05       Impact factor: 1.731

6.  Longer duration of catheter patency, but similar infection rates with internal jugular vein versus iliac vein tunneled cuffed hemodialysis catheters: a single-center retrospective analysis.

Authors:  Lihua Wang; Fang Wei; Aili Jiang; Haiyan Chen; Guijiang Sun; Xueqing Bi
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

7.  Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease.

Authors:  Raul J Guzman; D Marshal Brinkley; Paul M Schumacher; Rafe M J Donahue; Holly Beavers; Xiao Qin
Journal:  J Am Coll Cardiol       Date:  2008-05-20       Impact factor: 24.094

8.  Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.

Authors:  Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Brad C Astor; Ron C Hoogeveen; Scott D Solomon; Christie M Ballantyne; Mark Woodward; Josef Coresh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-29       Impact factor: 8.311

9.  Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

Authors:  Elena Aikawa; Masanori Aikawa; Peter Libby; Jose-Luiz Figueiredo; Gabriel Rusanescu; Yoshiko Iwamoto; Daiju Fukuda; Rainer H Kohler; Guo-Ping Shi; Farouc A Jaffer; Ralph Weissleder
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Does L-carnitine improve endothelial function in hemodialysis patients?

Authors:  Mohammad Reza Sabri; Farnaz Fahimi; Soheila Hajialiasgar; Abbas Etminan; Sarir Nazemi; Farzaneh Salehi
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.